Posted by Michael Wonder on 27 Oct 2015
Public consultation starts on PRIME - a new scheme to optimise development of priority medicines and facilitate patients’ access
26 October 2015 - PRIME aims to strengthen support to medicines that have the potential to benefit patients who presently have no treatment options, or that may offer a major therapeutic advantage over existing treatments.
For more details, go to: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/10/news_detail_002424.jsp&mid=WC0b01ac058004d5c1
